168 related articles for article (PubMed ID: 18622428)
21. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
22. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of NF-kappaB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance.
Anto RJ; Venkatraman M; Karunagaran D
J Biol Chem; 2003 Jul; 278(28):25490-8. PubMed ID: 12714587
[TBL] [Abstract][Full Text] [Related]
24. Interruption of NFkappaB-STAT1 signaling mediates EGF-induced cell-cycle arrest.
Ohtsubo M; Takayanagi A; Gamou S; Shimizu N
J Cell Physiol; 2000 Jul; 184(1):131-7. PubMed ID: 10825242
[TBL] [Abstract][Full Text] [Related]
25. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Kim DS; Park SS; Nam BH; Kim IH; Kim SY
Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK; Cruz AP; Gansberger E; Pardee AB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
28. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
30. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
[TBL] [Abstract][Full Text] [Related]
31. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
32. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
33. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.
Mordmüller B; Krappmann D; Esen M; Wegener E; Scheidereit C
EMBO Rep; 2003 Jan; 4(1):82-7. PubMed ID: 12524526
[TBL] [Abstract][Full Text] [Related]
34. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
35. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor (EGF) triggers the malignancy of hemangioma cells via activation of NF-κB signals.
Zhang L; Zhang J; Chen Z; Wang L; Wu X; Ou M
Biomed Pharmacother; 2016 Aug; 82():133-40. PubMed ID: 27470348
[TBL] [Abstract][Full Text] [Related]
37. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
38. Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells.
Le Page C; Koumakpayi IH; Lessard L; Saad F; Mes-Masson AM
Prostate; 2005 Dec; 65(4):306-15. PubMed ID: 16015604
[TBL] [Abstract][Full Text] [Related]
39. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.
Chen Y; Shu W; Chen W; Wu Q; Liu H; Cui G
Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):427-33. PubMed ID: 17927689
[TBL] [Abstract][Full Text] [Related]
40. Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-α in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
Furukawa C; Fujii N; Manabe A; Matsunaga T; Endo S; Hasegawa H; Ito Y; Yamaguchi M; Yamazaki Y; Ikari A
J Cell Physiol; 2017 Oct; 232(10):2841-2850. PubMed ID: 27925186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
